Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Free Cash Flow (2023 - 2025)

Fractyl Health's Free Cash Flow history spans 3 years, with the latest figure at -$21.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 23.58% year-over-year to -$21.3 million, compared with a TTM value of -$90.9 million through Dec 2025, down 35.07%, and an annual FY2025 reading of -$90.9 million, down 35.07% over the prior year.
  • Free Cash Flow for Q4 2025 was -$21.3 million at Fractyl Health, up from -$22.7 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$9.6 million in Q1 2023, with the low at -$25.5 million in Q1 2025.
  • Average Free Cash Flow over 3 years is -$16.8 million, with a median of -$17.6 million recorded in 2024.
  • Biggest YoY gain for Free Cash Flow was 17.3% in 2025; the steepest drop was 99.9% in 2025.
  • Tracing GUTS's Free Cash Flow over 3 years: stood at -$10.5 million in 2023, then crashed by 64.97% to -$17.3 million in 2024, then fell by 23.58% to -$21.3 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Free Cash Flow are -$21.3 million (Q4 2025), -$22.7 million (Q3 2025), and -$21.3 million (Q2 2025).